This brand name is authorized in Nigeria.
The drug AZOTEK contains one active pharmaceutical ingredient (API):
1
|
UNII
5FD1131I7S - AZITHROMYCIN DIHYDRATE
|
|
Azithromycin is a macrolide antibiotic belonging to the azalide group. The molecule is constructed by adding a nitrogen atom to the lactone ring of erythromycin A. The mechanism of action of azithromycin is based upon the suppression of bacterial protein synthesis by means of binding to the ribosomal 50S sub-unit and inhibition of peptide translocation. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| B4-5480 | Tablet | AZOTEK 500MG TABLET TAB 500 mg 1 X 6Tablets | 29 RNW-PP-170603 AZOTEK 500MG TABLET AZITHROMYCIN DIHYDRATE 500mg List of Excipients: PVP K-30, Avicel 200, Aerosil 200, Primogel, Magnesium stearate, Methanol, Opadry White, PEG 6000, Purified Water B4-5480 Drugs Imported Products 1x6Tablets Prescription Only Medicine (POM) 10/15/2020 NURUSHAT VENTURES LIMITED, FARAMOBI AJIKE STREET ANTHONY VILLAGE ANTHONY VILLAGE LAGOS 12347658 yomee_penners5@yahoo.com SAFFRON PHARMACEUTICALS (PVT) LTD, 19Km, Sheikhupura Road, Faisalabad-Pakistan, Pakistan | 27/07/2023 |
| B4-5481 | Tablet | AZOTEK 250MG TABLET TAB 250 mg 1x6 Tablets | AZOTEK 250MG TABLET AZITHROMYCIN DIHYDRATE 250mg ist of Excipients: PVP K-30, Avicel 200 , Aerosil 200, Primogel, Magnesium, stearate, Methanol , Opadry , White PEG, 6000 Purified Water B4-5481 Drugs Imported Products 1x6 Tablets Prescription Only Medicine (POM) 15/10/2020 NURUSHAT VENTURES LIMITED, FARAMOBI AJIKE STREET ANTHONY VILLAGE ANTHONY VILLAGE LAGOS 12347658 yomee_penners5@yahoo.com SAFFRON PHARMACEUTICALS (PVT) LTD, 19Km, Sheikhupura Road, Faisalabad-Pakistan, Pakistan | 31/08/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J01FA10 | Azithromycin | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FA Macrolides |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | B4-5480, B4-5481 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.